Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2020-06-25 08:00Moberg Pharma meets primary endpoint in the European Phase 3 studyRead more 2020-05-29 08:00New number of shares and votes in Moberg Pharma AB (publ)Read more 2020-05-19 16:30The board of directors exercises authorizations to issue and repurchase C-sharesRead more 2020-05-12 08:00Interim report January - March 2020Read more 2020-05-05 08:00Moberg Pharma's Interim report for July 2019 - March 2020 to be published on May 12 - Invitation to teleconferenceRead more 2020-04-28 18:00Bulletin from Moberg Pharma's Extraordinary General Meeting on April 28[th], 2020Read more Pagination First page Previous page … Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Page 30 … Next page Last page Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2019-03-22 08:30Moberg Pharma completes enrollment for MOB-015 Phase 3 study in EuropeRead more 2019-03-15 17:00Bulletin from Moberg Pharma's Extraordinary General Meeting 15 March 2019Read more 2019-03-04 08:30Moberg Pharma publishes information document on the proposed divestment of the OTC-businessRead more 2019-02-13 09:45Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)Read more 2019-02-12 01:01Moberg Pharma AB Year-end report 2018Read more 2019-02-12 01:00Moberg Pharma divests its OTC-business for USD 155 million and secures new funding for MOB-015 in transformational transactionRead more Pagination First page Previous page … Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Page 30 … Next page Last page
